Pharmaceutical Industry

Page 14 of 100

Bill Anderson, chief executive officer of Bayer
Leadership

Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion

By
April 11, 2024
Pascal Soriot, chief executive officer of Astrazeneca Plc, arrives at the CEO council at the Great Hall of the People in Beijing, Chin
Success

Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO

By
April 10, 2024
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
Health

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

By Carla K. Johnson and The Associated Press
April 8, 2024
ALS drug will be pulled from US market after study showed patients didn’t benefit
Health

ALS drug will be pulled from US market after study showed patients didn’t benefit

By Matthew Perrone and The Associated Press
April 4, 2024
It’s time for facts in the PBM debate
Commentary

It’s time for facts in the PBM debate

By
April 3, 2024
photo portrait of a middle aged man wearing a suit and tie
Newsletters

Johnson & Johnson CIO says employee upskilling is key to transforming health care

By
April 3, 2024
Pharmacies
Health

‘This is an emergency’: Trade group warns nearly a third of all independent pharmacies will go extinct because of a CMS rule

By Maia Anderson, Healthcare Brew and Morning Brew
March 30, 2024
An out-of-focus person is point to their left and is standing in front of a window with the red and white Walgreens 'W' on it.
Retail

Walgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says

By
March 29, 2024
The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives
Commentary

The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives

By
March 28, 2024
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Health

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

By Madison Muller, Robert Langreth and Bloomberg
March 28, 2024
China woos CEOs of Apple, chipmakers, pharma giants as geopolitical tensions mount: ‘The risk-reward has changed’
Leadership

China woos CEOs of Apple, chipmakers, pharma giants as geopolitical tensions mount: ‘The risk-reward has changed’

By
March 23, 2024
Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
Commentary

Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it

By
March 21, 2024
After testing new drug compounds that appear to mimic the physical benefits of exercise in rodents, scientists say a pill may someday be able to do the same in humans.
Life

An exercise pill may soon offer the same benefits as a workout, scientists say

By
March 18, 2024
A man with glasses and a white lab coat stands in front of a glass wall in a medical research facility.
Newsletters

How AI turbocharged the development of a new drug and what it might mean for health care

By
March 14, 2024
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
Health

FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug

By Tom Murphy, Matthew Perrone and The Associated Press
March 8, 2024

Most Popular